Welcome to our dedicated page for Gevo SEC filings (Ticker: GEVO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Gevo, Inc. filings document the company’s renewable-fuels business, Nasdaq-listed common stock, operating results and material corporate events. Form 8-K reports include quarterly and annual financial results, business updates for low-carbon ethanol, carbon management, synthetic aviation fuel initiatives, and material financing or refinancing arrangements involving company subsidiaries.
Proxy and governance filings cover director elections, board composition, auditor ratification, executive compensation votes and officer transitions. The filing record also documents credit agreements, working-capital facilities, renewable natural gas project debt matters, compensatory arrangements and other disclosures related to Gevo’s capital structure, governance and project-development strategy.
Andrew Shafer, Chief Customer, Marketing & Brand Officer at Gevo (GEVO), reported insider sales under a pre-established trading plan. On 09/22/2025 he disposed of 5,000 shares of Gevo common stock at a weighted-average price of $2.0124 per share, with the sales executed pursuant to a 10b5-1 plan adopted on November 22, 2024. Following the reported transactions, the filing shows the reporting person beneficially owned 320,620 shares directly and an additional 9,803.21 shares indirectly through a 401(k) plan. The filing notes that 3.71 shares were disposed under the 401(k) to cover administrative fees between 08/20/2025 and 09/22/2025.
Andrew Shafer, Chief Customer, Marketing & Brand Officer at Gevo (GEVO), reported insider sales under a pre-established trading plan. On 09/22/2025 he disposed of 5,000 shares of Gevo common stock at a weighted-average price of $2.0124 per share, with the sales executed pursuant to a 10b5-1 plan adopted on November 22, 2024. Following the reported transactions, the filing shows the reporting person beneficially owned 320,620 shares directly and an additional 9,803.21 shares indirectly through a 401(k) plan. The filing notes that 3.71 shares were disposed under the 401(k) to cover administrative fees between 08/20/2025 and 09/22/2025.
Paul D. Bloom, Chief Business Officer of Gevo, Inc. (GEVO), reported a transaction on 09/17/2025 selling 75,000 shares of common stock to cover tax withholding on vested restricted stock. The sales were effected under a 10b5-1 trading plan adopted November 21, 2024, at a weighted-average price of $2.0058 per share, with individual sale prices ranging from $2.00 to $2.03. After the disposition, Mr. Bloom beneficially owns 923,591 shares directly and 22,039.17 shares indirectly through a 401(k) plan. The filing discloses the routine nature of the sale and offers availability of detailed per-price sale information on request.
Paul D. Bloom, Chief Business Officer of Gevo, Inc. (GEVO), reported a transaction on 09/17/2025 selling 75,000 shares of common stock to cover tax withholding on vested restricted stock. The sales were effected under a 10b5-1 trading plan adopted November 21, 2024, at a weighted-average price of $2.0058 per share, with individual sale prices ranging from $2.00 to $2.03. After the disposition, Mr. Bloom beneficially owns 923,591 shares directly and 22,039.17 shares indirectly through a 401(k) plan. The filing discloses the routine nature of the sale and offers availability of detailed per-price sale information on request.
Gevo, Inc. filed an 8-K disclosing a Carbon Dioxide Removal Sales Agreement dated September 18, 2025 between Net‑Zero Richardton, LLC and Biorecro North America, LLC. The filing appears as a material event notice and includes cover page information and an interactive data reference. The document identifies Gevo's principal office in Englewood, CO and lists an officer signature by E. Cabell Massey, Vice President, Legal and Corporate Secretary. The filing provides the existence and counterparties of the agreement but does not disclose contract value, volumes, pricing, delivery schedule, or other commercial or financial terms, so material economic impact cannot be assessed from the text provided.
Gevo, Inc. filed an 8-K disclosing a Carbon Dioxide Removal Sales Agreement dated September 18, 2025 between Net‑Zero Richardton, LLC and Biorecro North America, LLC. The filing appears as a material event notice and includes cover page information and an interactive data reference. The document identifies Gevo's principal office in Englewood, CO and lists an officer signature by E. Cabell Massey, Vice President, Legal and Corporate Secretary. The filing provides the existence and counterparties of the agreement but does not disclose contract value, volumes, pricing, delivery schedule, or other commercial or financial terms, so material economic impact cannot be assessed from the text provided.
Form 144 notice for Gevo, Inc. (GEVO) indicates a proposed sale of 225,000 shares of common stock through Stifel Nicolaus & Company, with an aggregate market value of $451,305.00. The shares are scheduled for sale approximately on 09/17/2025 on the Nasdaq. The filing states the securities were acquired as Restricted Stock Units on 08/20/2021 from the issuer, totaling 392,175 shares acquired on that date and with cash payment noted.
The filing also discloses recent sales by the same person, Paul Bloom, totaling several transactions in August and September 2025 (largest single prior sale listed: 33,073 shares on 08/05/2025). The notice includes the standard signature representation that the seller is not aware of undisclosed material adverse information.
Gevo, Inc. filed a current report to notify investors that it has posted a revised investor presentation on its website at investors.gevo.com. The updated materials, dated September 9, 2025, are also furnished as Exhibit 99.1 to this report, giving shareholders a consolidated source of the latest company information and outlook.
The company notes that the investor presentation and related disclosure under Item 7.01 are being furnished rather than filed, meaning they are not subject to certain liability provisions of the Exchange Act and are not automatically incorporated into other Securities Act or Exchange Act filings unless specifically referenced.
Kimberly T. Bowron, Chief People and IT Officer of Gevo, Inc. (GEVO), reported insider share dispositions on 09/04/2025. She sold 1,530 shares of Gevo common stock to cover tax withholding from a restricted stock vesting, with a weighted average sale price of $1.6295 (sales ranged from $1.61 to $1.64). The sales were effected pursuant to a 10b5-1 trading plan adopted December 2, 2024. After the reported sale, Bowron beneficially owns 481,226 shares directly and holds 7,864.35 shares indirectly through the company 401(k) plan. The report also discloses that between August 5, 2025 and September 4, 2025 the reporting person disposed of 2.99 shares under the 401(k) plan to cover administrative fees. The Form 4 was signed by attorney-in-fact E. Cabell Massey on 09/05/2025.
Agiri Oluwagbemileke Yusuf, Chief Financial Officer of Gevo, Inc. (GEVO), reported sales and plan-related disposals in a Form 4 filing. On 09/04/2025 the reporting person sold 1,731 shares of GEVO common stock to satisfy tax withholding obligations arising from the vesting of a restricted stock award; the sales were made under a 10b5-1 trading plan adopted on 11/22/2024 at a weighted average price of $1.6295 per share (individual trade prices ranged from $1.61 to $1.64). After the reported sale the reporting person beneficially owned 276,104 shares directly and held 18,970.28 shares indirectly through a 401(k) plan. Separately, between 08/20/2025 and 09/04/2025 the reporting person disposed of 7.29 shares under the issuer's 401(k) plan to cover administrative fees. The Form 4 was signed by an attorney-in-fact on 09/05/2025.
Gevo, Inc. (GEVO) insider Form 4: Paul D. Bloom, Chief Business Officer, reported sales of 2,092 shares of Gevo common stock on 09/04/2025 at a weighted average price of $1.6298 per share (individual trades ranged $1.61–$1.64). The sales were executed pursuant to a 10b5-1 trading plan adopted November 21, 2024, and were used to satisfy tax-withholding obligations upon vesting of a restricted stock award. The report also notes the reporting person holds 998,591 shares directly and 22,039.17 shares indirectly through the company 401(k) plan, with 8.4 401(k) shares disposed between August 5, 2025 and September 4, 2025 to cover administrative fees.
Gevo, Inc. insider filing (Form 4) shows President & COO Ryan Christopher Michael sold 1,683 shares of Gevo common stock on 09/04/2025 at a weighted average price of $1.6295 per share to cover tax withholding on vesting restricted stock awards. The sales were made under a 10b5-1 trading plan adopted November 26, 2024. After the reported transactions the reporting person beneficially owned 1,631,938 shares directly and held an indirect position of 22,016.68 shares through a 401(k) plan. The filing also notes the disposition of 8.35 shares from the 401(k) between 08/05/2025 and 09/04/2025 to cover administrative fees.
Patrick R. Gruber, Gevo, Inc. CEO and Director, reported insider share disposals on Form 4 dated 09/05/2025 reflecting transactions on 09/04/2025. The filing shows 1,642 shares sold at a weighted average price of $1.6295 per share under a 10b5-1 plan to cover tax withholding upon vesting of a restricted stock award. After the reported sale, Mr. Gruber beneficially owns 3,845,462 shares directly.
The filing also notes 22,017.45 shares held indirectly through a 401(k) plan and a separate disposal of 8.51 shares under the 401(k) between August 5, 2025 and September 4, 2025 to cover administrative fees. The 10b5-1 plan was adopted on November 14, 2024.